Literature DB >> 4520419

Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.

E Frei, F M Schabel, A Goldin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4520419

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

1.  Chemotherapy studies in autochthonous rat tumors: hepatomas.

Authors:  M Habs; G Habs; D Schmähl
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-11-18

2.  Current issues in the management of children with acute lymphocytic leukaemia.

Authors:  D Pinkel
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401

3.  Prolonged survival of AKR mice following allogeneic bone marrow transplantation.

Authors:  W C Rose; M M Bortin; E C Saltzstein
Journal:  Experientia       Date:  1974-09-15

4.  Differential metastatic capacity of three AKR lymphoma variants.

Authors:  J Leibovici; O Klein; H Argaman; G Klorin; M Michowitz
Journal:  Int J Exp Pathol       Date:  1992-06       Impact factor: 1.925

5.  Experimental chemotherapy with N'N'-bis(2-chloroethyl)-N-nitrosourea (BCNU) in autochthonous neurogenic tumors of the rat transplacentally induced by ethylnitrosourea.

Authors:  H H Fiebig; H Strobel; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

Review 6.  The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review.

Authors:  A Goldin; J M Venditti; R Geran
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

7.  Chemotherapy studies in autochthonous rat tumors. Forestomach and bladder cancer.

Authors:  M Habs; J Ang; D Schmähl
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-06-27

8.  Lessons from 20 years of curative therapy of childhood acute leukaemia.

Authors:  D Pinkel
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.